Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observations

OBJECTIVE: To track the clinical outcomes in patients who initially presented with tumefactive demyelinating lesions (TDLs), we summarized the clinical characteristics of various etiologies, and identified possible relapse risk factors for TDLs. METHODS: Between 2001 and 2021, 116 patients initially...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinnan, Miao, Xiuling, Wang, Yaming, Sun, Junzhao, Gao, Haifeng, Han, Jing, Li, Yuxin, Wang, Qingjun, Sun, Chenjing, Liu, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752826/
https://www.ncbi.nlm.nih.gov/pubmed/36532021
http://dx.doi.org/10.3389/fimmu.2022.1052678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752826/
https://www.ncbi.nlm.nih.gov/pubmed/36532021
http://dx.doi.org/10.3389/fimmu.2022.1052678

Ejemplares similares